Join
Live feed
·
PRReleasevia Quantisnow
Sutro Biopharma Inc. logo
Celgene Corporation logo

Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer

ByQuantisnow·Wall Street's wire, on your screen.
STRO· Sutro Biopharma Inc.CELG~· Celgene Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STRO (Sutro Biopharma Inc.), CELG~ (Celgene Corporation) and more on Quantisnow.

Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer | Quantisnow